The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tumor Targeted Drug Detection Kit Market Research Report 2024

Global Tumor Targeted Drug Detection Kit Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1884324

No of Pages : 101

Ask Your Query
Synopsis
This kit is an in vitro diagnostic reagent based on second-generation sequencing technology. Detection of common driver gene mutations in non-small cell lung cancer (EGFR, ALK, ROS1, BRAF, RET, ERBB2, NTRK, KRAS, etc.) and immunotherapy positive/negative/hyper-progression related genes. The types of mutations detected include point mutations, Insertions, deletions, rearrangements, fusions. The applicable sample type is paraffin-embedded tissue sample (FFPE).
The global Tumor Targeted Drug Detection Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Targeted Drug Detection Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Targeted Drug Detection Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tumor Targeted Drug Detection Kit include BGI, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA and Pathway Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Targeted Drug Detection Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Targeted Drug Detection Kit.
Report Scope
The Tumor Targeted Drug Detection Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Targeted Drug Detection Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Targeted Drug Detection Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BGI
Quest Diagnostics
Gene By Gene（myDNA Inc.）
DNA Diagnostics Center
Invitae
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
Segment by Type
Single Gene Testing
Multigene Testing
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tumor Targeted Drug Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tumor Targeted Drug Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Tumor Targeted Drug Detection Kit Market Overview
1.1 Product Overview and Scope of Tumor Targeted Drug Detection Kit
1.2 Tumor Targeted Drug Detection Kit Segment by Type
1.2.1 Global Tumor Targeted Drug Detection Kit Market Value Comparison by Type (2024-2030)
1.2.2 Single Gene Testing
1.2.3 Multigene Testing
1.3 Tumor Targeted Drug Detection Kit Segment by Application
1.3.1 Global Tumor Targeted Drug Detection Kit Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Tumor Targeted Drug Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Tumor Targeted Drug Detection Kit Revenue 2019-2030
1.4.2 Global Tumor Targeted Drug Detection Kit Sales 2019-2030
1.4.3 Global Tumor Targeted Drug Detection Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tumor Targeted Drug Detection Kit Market Competition by Manufacturers
2.1 Global Tumor Targeted Drug Detection Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tumor Targeted Drug Detection Kit Average Price by Manufacturers (2019-2024)
2.4 Global Tumor Targeted Drug Detection Kit Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Product Type & Application
2.7 Tumor Targeted Drug Detection Kit Market Competitive Situation and Trends
2.7.1 Tumor Targeted Drug Detection Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Targeted Drug Detection Kit Players Market Share by Revenue
2.7.3 Global Tumor Targeted Drug Detection Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Targeted Drug Detection Kit Retrospective Market Scenario by Region
3.1 Global Tumor Targeted Drug Detection Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tumor Targeted Drug Detection Kit Global Tumor Targeted Drug Detection Kit Sales by Region: 2019-2030
3.2.1 Global Tumor Targeted Drug Detection Kit Sales by Region: 2019-2024
3.2.2 Global Tumor Targeted Drug Detection Kit Sales by Region: 2025-2030
3.3 Global Tumor Targeted Drug Detection Kit Global Tumor Targeted Drug Detection Kit Revenue by Region: 2019-2030
3.3.1 Global Tumor Targeted Drug Detection Kit Revenue by Region: 2019-2024
3.3.2 Global Tumor Targeted Drug Detection Kit Revenue by Region: 2025-2030
3.4 North America Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.4.1 North America Tumor Targeted Drug Detection Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tumor Targeted Drug Detection Kit Sales by Country (2019-2030)
3.4.3 North America Tumor Targeted Drug Detection Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.5.1 Europe Tumor Targeted Drug Detection Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tumor Targeted Drug Detection Kit Sales by Country (2019-2030)
3.5.3 Europe Tumor Targeted Drug Detection Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Targeted Drug Detection Kit Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tumor Targeted Drug Detection Kit Sales by Country (2019-2030)
3.6.3 Asia Pacific Tumor Targeted Drug Detection Kit Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Tumor Targeted Drug Detection Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tumor Targeted Drug Detection Kit Sales by Country (2019-2030)
3.7.3 Latin America Tumor Targeted Drug Detection Kit Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Targeted Drug Detection Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tumor Targeted Drug Detection Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tumor Targeted Drug Detection Kit Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Targeted Drug Detection Kit Sales by Type (2019-2030)
4.1.1 Global Tumor Targeted Drug Detection Kit Sales by Type (2019-2024)
4.1.2 Global Tumor Targeted Drug Detection Kit Sales by Type (2025-2030)
4.1.3 Global Tumor Targeted Drug Detection Kit Sales Market Share by Type (2019-2030)
4.2 Global Tumor Targeted Drug Detection Kit Revenue by Type (2019-2030)
4.2.1 Global Tumor Targeted Drug Detection Kit Revenue by Type (2019-2024)
4.2.2 Global Tumor Targeted Drug Detection Kit Revenue by Type (2025-2030)
4.2.3 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Type (2019-2030)
4.3 Global Tumor Targeted Drug Detection Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tumor Targeted Drug Detection Kit Sales by Application (2019-2030)
5.1.1 Global Tumor Targeted Drug Detection Kit Sales by Application (2019-2024)
5.1.2 Global Tumor Targeted Drug Detection Kit Sales by Application (2025-2030)
5.1.3 Global Tumor Targeted Drug Detection Kit Sales Market Share by Application (2019-2030)
5.2 Global Tumor Targeted Drug Detection Kit Revenue by Application (2019-2030)
5.2.1 Global Tumor Targeted Drug Detection Kit Revenue by Application (2019-2024)
5.2.2 Global Tumor Targeted Drug Detection Kit Revenue by Application (2025-2030)
5.2.3 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Application (2019-2030)
5.3 Global Tumor Targeted Drug Detection Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BGI
6.1.1 BGI Corporation Information
6.1.2 BGI Description and Business Overview
6.1.3 BGI Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BGI Tumor Targeted Drug Detection Kit Product Portfolio
6.1.5 BGI Recent Developments/Updates
6.2 Quest Diagnostics
6.2.1 Quest Diagnostics Corporation Information
6.2.2 Quest Diagnostics Description and Business Overview
6.2.3 Quest Diagnostics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Quest Diagnostics Tumor Targeted Drug Detection Kit Product Portfolio
6.2.5 Quest Diagnostics Recent Developments/Updates
6.3 Gene By Gene（myDNA Inc.）
6.3.1 Gene By Gene（myDNA Inc.） Corporation Information
6.3.2 Gene By Gene（myDNA Inc.） Description and Business Overview
6.3.3 Gene By Gene（myDNA Inc.） Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gene By Gene（myDNA Inc.） Tumor Targeted Drug Detection Kit Product Portfolio
6.3.5 Gene By Gene（myDNA Inc.） Recent Developments/Updates
6.4 DNA Diagnostics Center
6.4.1 DNA Diagnostics Center Corporation Information
6.4.2 DNA Diagnostics Center Description and Business Overview
6.4.3 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Product Portfolio
6.4.5 DNA Diagnostics Center Recent Developments/Updates
6.5 Invitae
6.5.1 Invitae Corporation Information
6.5.2 Invitae Description and Business Overview
6.5.3 Invitae Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Invitae Tumor Targeted Drug Detection Kit Product Portfolio
6.5.5 Invitae Recent Developments/Updates
6.6 Ambry Genetics
6.6.1 Ambry Genetics Corporation Information
6.6.2 Ambry Genetics Description and Business Overview
6.6.3 Ambry Genetics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ambry Genetics Tumor Targeted Drug Detection Kit Product Portfolio
6.6.5 Ambry Genetics Recent Developments/Updates
6.7 Living DNA
6.6.1 Living DNA Corporation Information
6.6.2 Living DNA Description and Business Overview
6.6.3 Living DNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Living DNA Tumor Targeted Drug Detection Kit Product Portfolio
6.7.5 Living DNA Recent Developments/Updates
6.8 EasyDNA
6.8.1 EasyDNA Corporation Information
6.8.2 EasyDNA Description and Business Overview
6.8.3 EasyDNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 EasyDNA Tumor Targeted Drug Detection Kit Product Portfolio
6.8.5 EasyDNA Recent Developments/Updates
6.9 Pathway Genomics
6.9.1 Pathway Genomics Corporation Information
6.9.2 Pathway Genomics Description and Business Overview
6.9.3 Pathway Genomics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pathway Genomics Tumor Targeted Drug Detection Kit Product Portfolio
6.9.5 Pathway Genomics Recent Developments/Updates
6.10 Centrillion Technology
6.10.1 Centrillion Technology Corporation Information
6.10.2 Centrillion Technology Description and Business Overview
6.10.3 Centrillion Technology Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Centrillion Technology Tumor Targeted Drug Detection Kit Product Portfolio
6.10.5 Centrillion Technology Recent Developments/Updates
6.11 Color Genomics
6.11.1 Color Genomics Corporation Information
6.11.2 Color Genomics Tumor Targeted Drug Detection Kit Description and Business Overview
6.11.3 Color Genomics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Color Genomics Tumor Targeted Drug Detection Kit Product Portfolio
6.11.5 Color Genomics Recent Developments/Updates
6.12 Anglia DNA Services
6.12.1 Anglia DNA Services Corporation Information
6.12.2 Anglia DNA Services Tumor Targeted Drug Detection Kit Description and Business Overview
6.12.3 Anglia DNA Services Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Anglia DNA Services Tumor Targeted Drug Detection Kit Product Portfolio
6.12.5 Anglia DNA Services Recent Developments/Updates
6.13 African Ancestry
6.13.1 African Ancestry Corporation Information
6.13.2 African Ancestry Tumor Targeted Drug Detection Kit Description and Business Overview
6.13.3 African Ancestry Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.13.4 African Ancestry Tumor Targeted Drug Detection Kit Product Portfolio
6.13.5 African Ancestry Recent Developments/Updates
6.14 Canadian DNA Services
6.14.1 Canadian DNA Services Corporation Information
6.14.2 Canadian DNA Services Tumor Targeted Drug Detection Kit Description and Business Overview
6.14.3 Canadian DNA Services Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Canadian DNA Services Tumor Targeted Drug Detection Kit Product Portfolio
6.14.5 Canadian DNA Services Recent Developments/Updates
6.15 DNA Family Check
6.15.1 DNA Family Check Corporation Information
6.15.2 DNA Family Check Tumor Targeted Drug Detection Kit Description and Business Overview
6.15.3 DNA Family Check Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.15.4 DNA Family Check Tumor Targeted Drug Detection Kit Product Portfolio
6.15.5 DNA Family Check Recent Developments/Updates
6.16 Alpha Biolaboratories
6.16.1 Alpha Biolaboratories Corporation Information
6.16.2 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Description and Business Overview
6.16.3 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Product Portfolio
6.16.5 Alpha Biolaboratories Recent Developments/Updates
6.17 Test Me DNA
6.17.1 Test Me DNA Corporation Information
6.17.2 Test Me DNA Tumor Targeted Drug Detection Kit Description and Business Overview
6.17.3 Test Me DNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Test Me DNA Tumor Targeted Drug Detection Kit Product Portfolio
6.17.5 Test Me DNA Recent Developments/Updates
6.18 23 Mofang
6.18.1 23 Mofang Corporation Information
6.18.2 23 Mofang Tumor Targeted Drug Detection Kit Description and Business Overview
6.18.3 23 Mofang Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.18.4 23 Mofang Tumor Targeted Drug Detection Kit Product Portfolio
6.18.5 23 Mofang Recent Developments/Updates
6.19 Genetic Health
6.19.1 Genetic Health Corporation Information
6.19.2 Genetic Health Tumor Targeted Drug Detection Kit Description and Business Overview
6.19.3 Genetic Health Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Genetic Health Tumor Targeted Drug Detection Kit Product Portfolio
6.19.5 Genetic Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Targeted Drug Detection Kit Industry Chain Analysis
7.2 Tumor Targeted Drug Detection Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Targeted Drug Detection Kit Production Mode & Process
7.4 Tumor Targeted Drug Detection Kit Sales and Marketing
7.4.1 Tumor Targeted Drug Detection Kit Sales Channels
7.4.2 Tumor Targeted Drug Detection Kit Distributors
7.5 Tumor Targeted Drug Detection Kit Customers
8 Tumor Targeted Drug Detection Kit Market Dynamics
8.1 Tumor Targeted Drug Detection Kit Industry Trends
8.2 Tumor Targeted Drug Detection Kit Market Drivers
8.3 Tumor Targeted Drug Detection Kit Market Challenges
8.4 Tumor Targeted Drug Detection Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock